[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 191, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erick J. Lucera C.F.A., CPA", "age": 56, "title": "CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.99, "open": 12.04, "dayLow": 11.81, "dayHigh": 12.47, "regularMarketPreviousClose": 11.99, "regularMarketOpen": 12.04, "regularMarketDayLow": 11.81, "regularMarketDayHigh": 12.47, "payoutRatio": 0.0, "beta": 1.209, "forwardPE": -3.7531643, "volume": 1040609, "regularMarketVolume": 1040609, "averageVolume": 2120051, "averageVolume10days": 2619860, "averageDailyVolume10Day": 2619860, "bid": 8.82, "ask": 15.11, "bidSize": 2, "askSize": 2, "marketCap": 1347699200, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 47.45, "fiftyDayAverage": 10.9564, "twoHundredDayAverage": 25.46665, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 723339264, "profitMargins": 0.0, "floatShares": 97036631, "sharesOutstanding": 113634000, "sharesShort": 15267942, "sharesShortPriorMonth": 12383217, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1344, "heldPercentInsiders": 0.0069, "heldPercentInstitutions": 1.01063, "shortRatio": 5.88, "shortPercentOfFloat": 0.1545, "impliedSharesOutstanding": 113634000, "bookValue": 6.156, "priceToBook": 1.9265755, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -317417984, "trailingEps": -3.37, "forwardEps": -3.16, "enterpriseToEbitda": -2.114, "52WeekChange": -0.5481905, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 11.86, "targetHighPrice": 66.0, "targetLowPrice": 17.0, "targetMeanPrice": 47.85714, "targetMedianPrice": 50.0, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 14, "totalCash": 642268032, "totalCashPerShare": 5.678, "ebitda": -342212992, "totalDebt": 23988000, "quickRatio": 15.199, "currentRatio": 15.601, "debtToEquity": 3.809, "returnOnAssets": -0.50198, "returnOnEquity": -0.88034, "freeCashflow": -189470752, "operatingCashflow": -292368992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.0842378, "regularMarketPrice": 11.86, "corporateActions": [], "postMarketTime": 1746226650, "regularMarketTime": 1746216001, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Dyne Therapeutics, Inc.", "longName": "Dyne Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": -1.85497, "postMarketPrice": 11.64, "postMarketChange": -0.219999, "regularMarketChange": -0.13000011, "regularMarketDayRange": "11.81 - 12.47", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2120051, "fiftyTwoWeekLowChange": 5.4999995, "fiftyTwoWeekLowChangePercent": 0.8647798, "fiftyTwoWeekRange": "6.36 - 47.45", "fiftyTwoWeekHighChange": -35.59, "fiftyTwoWeekHighChangePercent": -0.7500527, "fiftyTwoWeekChangePercent": -54.819046, "earningsTimestamp": 1740659400, "earningsTimestampStart": 1746475200, "earningsTimestampEnd": 1747339200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.37, "epsForward": -3.16, "epsCurrentYear": -3.48434, "priceEpsCurrentYear": -3.403801, "fiftyDayAverageChange": 0.90359974, "fiftyDayAverageChangePercent": 0.082472324, "twoHundredDayAverageChange": -13.60665, "twoHundredDayAverageChangePercent": -0.5342929, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]